- Home
- CTXR vs BCTX Comparison
CTXR vs BCTX Comparison
Compare CTXR & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- BCTX
- Stock Information
- Founded
- CTXR 2007
- BCTX 2014
- Country
- CTXR United States
- BCTX Canada
- Employees
- CTXR N/A
- BCTX N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- CTXR Health Care
- BCTX Health Care
- Exchange
- CTXR Nasdaq
- BCTX Nasdaq
- Market Cap
- CTXR 14.6M
- BCTX 15.8M
- IPO Year
- CTXR N/A
- BCTX N/A
- Fundamental
- Price
- CTXR $1.03
- BCTX $3.51
- Analyst Decision
- CTXR Strong Buy
- BCTX Strong Buy
- Analyst Count
- CTXR 2
- BCTX 1
- Target Price
- CTXR $54.50
- BCTX $32.00
- AVG Volume (30 Days)
- CTXR 598.0K
- BCTX 42.8K
- Earning Date
- CTXR 05-13-2025
- BCTX 03-12-2025
- Dividend Yield
- CTXR N/A
- BCTX N/A
- EPS Growth
- CTXR N/A
- BCTX N/A
- EPS
- CTXR N/A
- BCTX N/A
- Revenue
- CTXR N/A
- BCTX N/A
- Revenue This Year
- CTXR N/A
- BCTX N/A
- Revenue Next Year
- CTXR N/A
- BCTX N/A
- P/E Ratio
- CTXR N/A
- BCTX N/A
- Revenue Growth
- CTXR N/A
- BCTX N/A
- 52 Week Low
- CTXR $1.15
- BCTX $0.35
- 52 Week High
- CTXR $26.25
- BCTX $7.87
- Technical
- Relative Strength Index (RSI)
- CTXR 27.09
- BCTX 43.11
- Support Level
- CTXR $1.21
- BCTX $3.44
- Resistance Level
- CTXR $2.28
- BCTX $4.36
- Average True Range (ATR)
- CTXR 0.20
- BCTX 0.36
- MACD
- CTXR -0.00
- BCTX -0.11
- Stochastic Oscillator
- CTXR 0.71
- BCTX 0.74
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.